About 2 results found for searched term "BI-1347" (0.124 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5318 | Zoligratinib | EGFR/HER2 |
| CH5183284;Debio 1347 | ||
| CH5183284 is a selective and orally available FGFR inhibitor with IC50 of 9.3 nM, 7.6 nM, 22 nM, and 290 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively. Phase 1. | ||
| M13597 | BI-1347 | CDK |
| BI-1347 is a potent CDK8 inhibitor extracted from patent WO2017202719A1, product I-003, has an IC50 of 1.1 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
